BRAF/MEK inhibition in melanoma patients with rare BRAF mutations

被引：0
|
作者：
Hassel, Jessica Cecile
Menzer, Christian
Menzies, Alexander M.
Carlino, Matteo S.
Long, Georgina V.
Kefford, Richard
Eigentler, Thomas K.
Johnson, Douglas Buckner
Schlaak, Max
Meiss, Frank
Schilling, Bastian
Gutzmer, Ralf
Pfoehler, Claudia
Meier, Friedegund Elke
Zimmer, Lisa
Haalck, Thomas
Thoms, Kai
Kopp-Schneider, Annette
Enk, Alexander
机构：
[1] Univ Heidelberg Hosp, Sect DermatoOncol, Dept Dermatol, Heidelberg, Germany
[2] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany
[3] Melanoma Inst Australia, Sydney, NSW, Australia
[4] Melanoma Inst Australia, Westmead & Blacktown Hosp, Sydney, NSW, Australia
[5] Univ Sydney, Sydney, NSW, Australia
[6] Univ Sydney, Mater Hosp, Melanoma Inst Australia, Sydney, NSW, Australia
[7] Royal North Shore Hosp, Sydney, NSW, Australia
[8] Westmead Hosp, Sydney, NSW, Australia
[9] Macquarie Univ, Sydney, NSW, Australia
[10] Univ Hosp Tubingen, Dept Dermatol, Tubingen, Germany
[11] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[12] Univ Hosp, Dept Dermatol, Cologne, Germany
[13] Univ Freiburg, Deparment Dermatol & Venereol, Freiburg, Germany
[14] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany
[15] Hannover Med Sch, Dept Dermatol, Skin Canc Ctr Hannover, Hannover, Germany
[16] Saarland Univ, Dept Dermatol, Med Ctr, Homburg, Germany
[17] Univ Carl Gustav Carus, Dresden, Germany
[18] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, Essen, Germany
[19] Univ Hosp Hamburg Eppendorf, Hamburg, Germany
[20] Univ Hosp Gottingen, Dept Dermatol, Gottingen, Germany
[21] German Canc Res Ctr, Div Biostatist, Heidelberg, Germany
[22] Univ Heidelberg Hosp, Dept Dermatol, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9542
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9542
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
    Flaherty, Keith T.
    Infante, Jeffery R.
    Daud, Adil
    Gonzalez, Rene
    Kefford, Richard F.
    Sosman, Jeffrey
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Ibrahim, Nageatte
    Kudchadkar, Ragini
    Burris, Howard A., III
    Falchook, Gerald
    Algazi, Alain
    Lewis, Karl
    Long, Georgina V.
    Puzanov, Igor
    Lebowitz, Peter
    Singh, Ajay
    Little, Shonda
    Sun, Peng
    Allred, Alicia
    Ouellet, Daniele
    Kim, Kevin B.
    Patel, Kiran
    Weber, Jeffrey
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18): : 1694 - 1703
  • [2] BRAF and MEK inhibition in melanoma
    Dossett, Lesly A.
    Kudchadkar, Ragini R.
    Zager, Jonathan S.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 559 - 570
  • [3] Combined inhibition of BRAF and MEK in melanoma patients
    Infante, Jeffrey R.
    Swanton, Charles
    [J]. LANCET ONCOLOGY, 2014, 15 (09): : 908 - 910
  • [4] Inhibition of BRAF and MEK in BRAF-mutant melanoma
    Smalley, Keiran S. M.
    Sondak, Vernon K.
    [J]. LANCET, 2015, 386 (9992): : 410 - 412
  • [5] Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
    Long, G. V.
    Stroyakovskiy, D.
    Gogas, H.
    Levchenko, E.
    de Braud, F.
    Larkin, J.
    Garbe, C.
    Jouary, T.
    Hauschild, A.
    Grob, J. J.
    Sileni, V. Chiarion
    Lebbe, C.
    Mandala, M.
    Millward, M.
    Arance, A.
    Bondarenko, I.
    Haanen, J. B. A. G.
    Hansson, J.
    Utikal, J.
    Ferraresi, V.
    Kovalenko, N.
    Mohr, P.
    Probachai, V.
    Schadendorf, D.
    Nathan, P.
    Robert, C.
    Ribas, A.
    DeMarini, D. J.
    Irani, J. G.
    Casey, M.
    Ouellet, D.
    Martin, A. -M.
    Le, N.
    Patel, K.
    Flaherty, K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20): : 1877 - 1888
  • [6] BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma
    Richman, Juliet
    Martin-Liberal, Juan
    Diem, Stefan
    Larkin, James
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (09) : 1285 - 1297
  • [7] Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma
    Smalley, Keiran S. M.
    Fedorenko, Inna V.
    [J]. MOLECULAR & CELLULAR ONCOLOGY, 2015, 2 (04)
  • [8] MEK Inhibition in BRAF-Mutated Melanoma
    MacKenzie, Alex
    Boycott, Kym
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14): : 1364 - 1365
  • [9] BRAF mutations increase response to MEK inhibition
    Ahmad, K
    [J]. LANCET ONCOLOGY, 2005, 6 (12): : 926 - 926
  • [10] Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to Melanoma
    Ilieva, Kristina M.
    Correa, Isabel
    Josephs, Debra H.
    Karagiannis, Panagiotis
    Egbuniwe, Isioma U.
    Cafferkey, Michiala J.
    Spicer, James F.
    Harries, Mark
    Nestle, Frank O.
    Lacy, Katie E.
    Karagiannis, Sophia N.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2769 - 2783
12345